Evidence map›Paper›PMID 32267855›Full record

ArticlePloS one2020

Diabetes prevalence by HbA1c and oral glucose tolerance test among HIV-infected and uninfected Tanzanian adults.

Kidola Jeremiah, Suzanne Filteau, Daniel Faurholt-Jepsen, Brenda Kitilya, Bazil B Kavishe, Rikke Krogh-Madsen, Mette F Olsen, John Changalucha, Andrea M Rehman, Nyagosya Range and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 3 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 4 countries.

Kidola JeremiahMwanza Research Centre, National Institute for Medical Research, Mwanza, Tanzania.ORCID 0000-0001-7900-9689
Suzanne FilteauFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Daniel Faurholt-JepsenDepartment of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0001-8561-0155
Brenda KitilyaMwanza Research Centre, National Institute for Medical Research, Mwanza, Tanzania.
Bazil B KavisheMwanza Research Centre, National Institute for Medical Research, Mwanza, Tanzania.ORCID 0000-0003-4839-4590
Rikke Krogh-MadsenCentre of Inflammation and Metabolism and Centre for Physical Activity Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Mette F OlsenDepartment of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
John ChangaluchaMwanza Research Centre, National Institute for Medical Research, Mwanza, Tanzania.
Andrea M RehmanFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.ORCID 0000-0001-9967-5822
Nyagosya RangeMuhimbili Medical Research Centre, National Institute for Medical Research, Dar es Salaam, Tanzania.
Jerome KamwelaTanzania Commission for AIDS, Dar es Salaam, Tanzania.
Kaushik RamaiyaHindu Mandal Hospital, Dar es Salaam, Tanzania.
Aase B AndersenDepartment of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Henrik FriisDepartment of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-2848-2940
Douglas C HeimburgerVanderbilt Institute for Global Health and Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States of America.ORCID 0000-0003-3551-9710
George PrayGodMwanza Research Centre, National Institute for Medical Research, Mwanza, Tanzania.
National Institute for Medical Research · TZUniversity of Copenhagen · DKLondon School of Hygiene & Tropical Medicine · GBRigshospitalet · DKAga Khan Hospital Dar es Salaam · TZTanzania Commission for AIDS · TZVanderbilt University Medical Center · US

Funding

Vanderbilt-Emory-Cornell-Duke Global Health Fellowship Consortium-Expanding Diversity for Global Equity (EDGE)D43TW009337 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALIYU, MUKTAR HASSAN, HEIMBURGER, DOUGLAS CORBETT · 2017 to 2021
$6.3M
FIC NIH HHS D43 TW009337Medical Research Council MR/R010161/1
6 · The paper itself

Abstract

backgroundThe burden of diabetes is increasing in sub-Saharan Africa, including among people living with HIV. We assessed the prevalence of diabetes and the roles of HIV, antiretroviral therapy (ART) and traditional risk factors among adults in Tanzania.

methodsWe analysed diabetes-relevant baseline data from 1,947 adult participants in the CICADA study in Mwanza, Tanzania: 655 HIV-uninfected, 956 HIV-infected ART-naïve, and 336 HIV-infected persons on ART. WHO guidelines for haemoglobin A1c (HbA1c) and oral glucose tolerance test (OGTT) were used to define diabetes and prediabetes. Risk factors were evaluated using multinomial logistic regression analysis. Relative risk ratios (RRR) were generated comparing participants with diabetes and prediabetes against the reference of those with no diabetes.

resultsMean age was 41 (SD 12) years; 59% were women. The prevalence of diabetes was 13% by HbA1c and 6% by OGTT, with partial overlap among participants identified by the two tests. Relative to HIV-uninfected, HIV-infected ART-naïve persons had increased relative risks of diabetes (HbA1c: RRR = 1.95, 95% CI 1.25-3.03; OGTT: RRR = 1.90, 95% CI 0.96-3.73) and prediabetes (HbA1c: RRR = 2.89, 95% CI 1.93-4.34; OGTT: RRR = 1.61, 95% CI 1.22-2.13). HIV-infected participants on ART showed increased risk of prediabetes (RRR 1.80, 95% CI 1.09, 2.94) by HbA1c, but not diabetes. CD4 count < 200 cell/μL at recruitment increased risk and physical activity decreased risk of diabetes by both HbA1c and OGTT.

conclusionsThe prevalence of diabetes was high, especially among HIV-infected ART-naïve adults. Being more physically active was associated with lower risk of diabetes. HbA1c and OGTT identified different participants as having diabetes or prediabetes. Overall, the finding of high burden of diabetes among HIV-infected persons suggests that health systems should consider integrating diabetes screening and treatment in HIV clinics to optimize the care of HIV patients and improve their health outcomes.

Indexed as

Glucose Tolerance TestAdolescentAdultAnti-HIV AgentsCross-Sectional StudiesDiabetes MellitusFemaleGlycated HemoglobinHIV InfectionsHumansMaleMiddle AgedPrevalenceRisk FactorsTanzaniaYoung AdultAnti-HIV AgentsGlycated Hemoglobin

Identifiers

PMID32267855
PMCPMC7141607
OpenAlexW3014431742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.